Comparative safety tolerance pharmacokinetics amphotericin lipid complex amphotericin desoxycholate healthy male volunteers Amphotericin lipid complex ABLC lipid complex formulation amphotericin amphotericin desoxycholate AB safety tolerance pharmacokinetics groups healthy male volunteers test dose study drug mg/kg dose subjects AB ABLC acute adverse effects mild somnolence drowsiness volunteers addition ABLC recipient asymptomatic transient serum transaminase elevations AB recipients acute side effects mild shaking chill sleepiness significant changes vital signs electrocardiogram oximetry pulmonary function clinical status group Due increased estimate volume distribution clearance ABLC amphotericin levels area serum concentration versus time relative AB 